Brandinium

Trademark search for:

EROZ-ONE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2003-03-13 — Application filed
  • 2003-08-14 — Assigned to examiner
  • 2003-08-18 — Case file in ticrs
  • 2003-08-19 — Final disposition recorded
  • 2003-10-06 — Office action issued
  • 2003-10-06 — Correspondence received in law office
  • 2004-01-12 — Fax received
  • 2004-03-16 — Approved for pub - principal register
  • 2004-05-12 — Notice of publication
  • 2004-06-01 — Published for opposition
  • 2004-06-21 — Extension of time to oppose received
  • 2004-07-16 — Opposition instituted no. 999999
  • 2004-08-05 — Opposition instituted no. 999999
  • 2004-09-14 — Petition to director received
  • 2005-01-27 — Opposition dismissed no. 999999
  • 2005-01-27 — Opposition terminated no. 999999
  • 2005-02-17 — Petition inquiry letter issued
  • 2005-04-19 — Application abandoned
  • 2005-04-19 — Application abandoned
  • 2005-04-19 — Opposition sustained no. 999999
  • 2005-04-19 — Opposition terminated no. 999999
  • 2005-04-19 — Final status recorded
  • 2005-05-05 — Petition to director dismissed
  • 2005-08-05 — Paper received
  • 2006-07-06 — Teas change of correspondence received

Owner Information

Megasol Cosmetic GmbH
Foehren DE
Megasol Cosmetic GmbH
Foehren DE

Correspondent

KATRIN LEWERTOFF SIDLEY AUSTIN LLP
787 7TH AVE
NEW YORK, NY 10019
UNITED STATES

Filing Details

Filing Date:
2003-03-13
Status Date:
2005-04-19
Category:
Pharmaceuticals
Filing Year:
2003

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.